Flumazenil
id:
flumazenil-179-1863886
title:
Flumazenil
text:
Flumazenil is a selective GABAA receptor antagonist administered via injection, otic insertion, or intranasally. Therapeutically, it acts as both an antagonist and antidote to benzodiazepines, through competitive inhibition. It was first characterized in 1981, and was first marketed in 1987 by Hoffmann-La Roche under the trade name Anexate. However, it did not receive FDA approval until December 20, 1991. The developer lost its exclusive patent rights in 2008; so at present, generic formulations
brand slug:
wiki
category slug:
encyclopedia
description:
GABA receptor antagonist drug and benzodiazepine antidote
original url:
https://en.wikipedia.org/wiki/Flumazenil
date created:
2004-07-24T23:42:20Z
date modified:
2024-09-04T19:17:12Z
main entity:
{"identifier":"Q421920","url":"https://www.wikidata.org/entity/Q421920"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/1/10/Flumazenil.svg","width":512,"height":344}
fields total:
13
integrity:
16